Background illustration for clinical trials search

Paid Clinical Trials Richmond

Discover 561 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for
Breast Cancer
Location: Mechanicsville VA, Greenwich CT, Stamford CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07062965

Phase3, Recruiting

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

for
Periodontitis (Stage 3)
Location: Richmond VA, New London CT, Boston MA, La Vista NE,
Sponsor: McGuire Institute

Sex: All

Age: 30 - 70+

Code: NCT06914596

Recruiting

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: Richmond VA, Baltimore MD, New York NY, Youngstown OH,
Sponsor: NGM Biopharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07033026

Phase2, Recruiting

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: Richmond VA, Bethesda MD, Philadelphia PA,
Sponsor: Rapport Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07563881

Phase3, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Richmond VA, Charlottesville VA, Durham NC, Raleigh NC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

for
Liver Neoplasms, Primary Liver Cancer, Secondary Liver Cancer,
Location: Richmond VA, Baltimore MD, Winston-Salem NC,
Sponsor: HistoSonics, Inc.

Sex: All

Age: 22+

Code: NCT06486454

Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Richmond VA, Pittsburgh PA, Myrtle Beach SC,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

Stratagen Quantitative Prostate MRI Platform Pilot Study

for
Prostate Cancer
Location: Richmond VA, Rochester NY
Sponsor: Stratagen Bio, Inc.

Sex: Male

Age: 40 - 70+

Code: NCT06985238

Recruiting

Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos

for
Complex Aneuploidy, Chaotic Aneuploidy
Location: Richmond VA, Norfolk VA, Fairfax VA, Rockville MD,
Sponsor: Shady Grove Fertility Reproductive Science Center

Sex: All

Age: 0+

Code: NCT07227116

Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: Richmond VA, Chevy Chase MD, Harrisburg PA,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase3, Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

for
Focal Epilepsy
Location: Richmond VA, Charlottesville VA, Bethesda MD,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06132893

Phase2, Phase3, Recruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

for
Metabolic Dysfunction Associated Steatohepatitis
Location: Richmond VA, Greenville NC, Raleigh NC, Lancaster PA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632457

Phase3, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Richmond VA, Chapel Hill NC, Philadelphia PA,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Richmond VA, Newport News VA, Fairfax VA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform

for
Any Solid Oral Medication
Location: Richmond VA, Madison WI, Minneapolis MN, Austin TX
Sponsor: Dosentrx Ltd.

Sex: All

Age: 18+

Code: NCT06344416

Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Richmond VA, Fredericksburg VA, South Hill VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Richmond VA, Midlothian VA, Fredericksburg VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

for
HR+/HER2- Breast Cancer
Location: Richmond VA, Fairfax VA, Wilson NC, Blacksburg VA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07492641

Phase3, Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

for
Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic,
Location: Richmond VA, Bethesda MD, Nashville TN,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05254743

Phase3, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Richmond VA, Charlottesville VA, Greenville NC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase3, Recruiting